Ouro Fino Saude Animal Participacoes SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ouro Fino Saude Animal Participacoes SA with three other
pharmaceutical manufacturers in Latin America:
Instituto Hermes Pardini SA
sales of 1.49 billion Brazilian Reals [US$279.68 million]
of which 100%
was auxiliary diagnostic support services),
Laboratorios Richmond SACIF
(6.18 billion Argentinian Pesos [US$62.74 million]
of which 66%
was Private Market), and
(2.97 billion Brazilian Reals [US$556.29 million]
of which 82%
was Diagnostic Medicine).
During the second
quarter of 2021, sales at Ouro Fino Saude Animal Participacoes SA totalled
230.98 million Brazilian Reals.
an increase of 33.9%
from the 172.54 million Brazilian Reals in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 399.77 million Brazilian Reals, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Ouro Fino Saude Animal Participacoes SA were 730.11 million Brazilian Reals (US$136.68 million).
increase of 17.8%
versus 2019, when the company's sales were 619.59 million Brazilian Reals.
This was the fourth straight year of sales growth at Ouro Fino Saude Animal Participacoes SA.
Sales of Internacional Operations saw an increase
34.9% in 2020, from
64.27 million Brazilian Reals to 86.71 million Brazilian Reals.